Physician profile
Ankit Modh
NPI 1518384916
$706.49
in general payments reported to CMS, 2019-2025
17 companies · $410 in 2025
The $410 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $125 · 2022: $39.47 · 2023: $90.84 · 2024: $41.69 · 2025: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $542.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $542.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $142.69 | 2024-2025 | Jakafi, Monjuvi, Zynyz |
| E.R. Squibb & Sons, L.L.C. | $124.67 | 2021 | |
| Abbvie INC. | $62.58 | 2025 | |
| Genentech USA, INC. | $60.73 | 2025 | Venclexta, Polivy, Itovebi |
| Takeda Pharmaceuticals U.S.A., INC. | $36.76 | 2023-2025 | Ninlaro, Iclusig |
| Servier Pharmaceuticals LLC | $35.93 | 2024-2025 | |
| Taiho Oncology, INC. | $35.17 | 2025 | |
| Ambu INC. | $29.45 | 2023 | |
| Celgene Corporation | $26.64 | 2025 | Opdivo |
| Macrogenics, INC. | $25.99 | 2022 | |
| Novartis Pharmaceuticals Corporation | $24.05 | 2025 | |
| Siemens Medical Solutions USA, INC. | $23.88 | 2023 | Somatom Go.Top |
| Puma Biotechnology, INC. | $19.04 | 2025 | |
| Teleflex LLC | $16.08 | 2025 | Barrigel |
| Regeneron Healthcare Solutions, INC. | $15.05 | 2023 | Libtayo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $14.30 | 2025 | |
| Jazz Pharmaceuticals INC. | $13.48 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ankit Modh listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.